WBSCR17 anticorps (AA 1-558)

N° du produit ABIN7869471

L’anticorps anti-WBSCR17 Polyclonal Lapin est utilisé pour la détection de WBSCR17 dans des échantillons de Humain, Souris et Rat. Il a été validé pour ELISA et WB.

Aperçu rapide pour WBSCR17 anticorps (AA 1-558) (ABIN7869471)

Antigène: WBSCR17 (Williams-Beuren Syndrome Chromosome Region 17 (WBSCR17))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp WBSCR17 est non-conjugé

Application: ELISA, Western Blotting (WB)

Détail du produit anti-WBSCR17 anticorps

Épitope: AA 1-558

Fonction: GALNT16 Antibody / Polypeptide N-acetylgalactosaminyltransferase 16

Purification: Immunogen affinity purified

Immunogène: E.coli-derived human GALNT16 recombinant protein (Position: M1-T558) was used as the immunogen for the GALNT16 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the GALNT16 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the GALNT16 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur WBSCR17

Antigène: WBSCR17 (Williams-Beuren Syndrome Chromosome Region 17 (WBSCR17))

Autre désignation: GALNT16

Sujet: GALNT16 antibody detects Polypeptide N-acetylgalactosaminyltransferase 16, a glycosyltransferase responsible for initiating mucin-type O-linked glycosylation of proteins. Encoded by the GALNT16 gene on chromosome 14q24.3, this enzyme belongs to the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family and catalyzes the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to serine or threonine residues of target proteins, forming the Tn antigen. GALNT16 participates in glycoprotein biosynthesis critical for cell signaling, adhesion, and extracellular communication.

Structurally, GALNT16 contains a catalytic domain responsible for GalNAc transferase activity and a C-terminal ricin-like lectin domain that enhances substrate recognition. It exhibits unique substrate specificity, preferentially modifying glycoproteins involved in neuronal signaling, epithelial maintenance, and immune responses. GALNT16 localizes to the Golgi apparatus, consistent with its function in post-translational modification and protein trafficking.

The GALNT16 antibody is widely used in glycobiology, cancer, and neurobiology research to investigate O-glycosylation pathways and their role in cellular communication. Western blot analysis identifies a 64 kilodalton band corresponding to GALNT16, while immunofluorescence reveals Golgi-localized perinuclear staining. This antibody provides a valuable tool for studying differential glycosylation patterns and their impact on protein stability and cell signaling.

Altered GALNT16 expression has been observed in cancers, where changes in O-glycosylation influence tumor cell invasion and immune evasion. Its expression in brain tissue also suggests involvement in synaptic regulation and neurodevelopment. The GALNT16 antibody enables exploration of how glycosylation controls key biological processes in health and disease. NSJ Bioreagents validates this antibody for its applications, ensuring reliability for glycosylation and protein modification studies.

UniProt: Q8N428